Skip to main content
Premium Trial:

Request an Annual Quote

Short Reads/Fingerprints: Jun 1, 2003

Premium

Pharma veteran George Poste, chairman of Orchid BioSciences and Structural Genomix, becomes director of the new Arizona Biodesign Institute, part of Arizona State University. The research facility will focus on using biotech, IT, and nanotechnology to find new ways of improving human health.

 

Aclara BioSciences continues tweaking its mission with a new hire: Michael Dunn, former executive VP for business development at ActivX Biosciences. Dunn will take on the new position of chief business officer for the Mountain View, Calif.-based company.

 

Simon Mercer heads to Gene Codes of Ann Arbor, Mich., as director of software engineering. He comes from previous work as director of the Canadian Bioinformatics Resource and a database development team leader at the Sanger Centre.

 

The Institute for Genomic Research hires Robert Strausberg, former director of NCI’s Cancer Genomics Office, as its vice president for research.

 

Kevin Ryan is the new president and CEO of Large Scale Biology, replacing founder Robert Erwin and John Fowler. Ryan was LSBC’s president from 1991 to 1995 and left to be CEO of contact lens manufacturer Wesley Jessen.

Formerly chief financial officer at Paris-based genomics firm Genset, John Varian is the new CFO at Deltagen.

 

Celera Genomics appoints Steven Ruben as its new veep for protein therapeutics. Ruben, who was last seen at Human Genome Sciences, will be responsible for work on discovering and validating new targets for therapeutics.

 

Matthew McGinniss, previously at Sequenom, moves to the Quest Diagnostics Nichols Institute as associate scientific director.

 

Tragically, leading Boston University bioethicist Dorothy Wertz died in a scuba-diving accident in Cancun, Mexico, during the Human Gene Mapping meeting in April.

 

Dynal Biotech announces the hiring of Erik Hornes as its CSO and VP of technology development. Hornes comes to Norway’s Dynal from Qiagen’s GenoVision unit.

 

DOE’s Pacific Northwest National Laboratory lures George Michaels from Monsanto to be its director of bioinformatics. Michaels, who also formerly worked at startup Genome Dynamics, will oversee PNNL’s bioinformatics and computational and systems biology efforts.

 

Exelixis bid adieu this month to its CFO and general counsel, Glen Sato, who becomes CFO at Protein Design Labs.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.